Medicaid Work Requirements 2027: Why CMS-2454-IFC Forces a Managed Care Capitation Reset

The 12-month Medicaid managed care rate development cycle was not designed to absorb a January 2027 enrollment shock. Under 42 CFR 438.4, states certifying capitation rates for managed care organizations must produce actuarially sound rates based on base period experience, credibility-weighted trend projections, and demographic adjustments reflecting the expected covered population. Rates for periods beginning July 2026 through June 2027 are being built right now against 2024 and 2025 claims data that captured none of the structural population shift now written into federal regulation. On June 1, 2026, the Centers for Medicare and Medicaid Services published CMS-2454-IFC in the Federal Register, implementing the community engagement requirement mandated by Section 44141 of the One Big Beautiful Bill Act and setting January 1, 2027 as the national compliance deadline. The people who will exit first are not a random cross-section of the enrolled population. That is the heart of the actuarial problem.

Building actuarial projections for managed Medicaid plan renewals has historically required adjusting for a predictable set of enrollment composition variables: Medicaid expansion income cliff effects, redetermination procedural loss rates, and age-sex distribution drift. CMS-2454-IFC adds a new dimension. Work requirement disenrollment selects against work-capable, moderate-acuity adults while the exemption categories explicitly retain the highest-acuity populations. Combined with the One Big Beautiful Bill Act's prohibition on Advanced Premium Tax Credits for work-requirement noncompliers, the structural dynamics concentrate risk in the Medicaid residual rather than redistributing it to other insurance markets. Actuaries certifying FY2027 and FY2028 rates under ASOP No. 49 face a population whose composition will diverge from any base period data available at certification time.

What CMS-2454-IFC Requires

CMS-2454-IFC (Federal Register Document No. 2026-11094, published June 3, 2026) imposes an 80-hour monthly community engagement standard on non-pregnant adults between the ages of 19 and 64 who are enrolled in Medicaid through the ACA expansion group or through certain Section 1115 waiver demonstrations providing minimum essential coverage. Qualifying activities include employment, participation in a qualifying work program or job skills training, enrollment in a postsecondary or vocational education program at least half-time, and volunteer community service. Enrollees may also satisfy the requirement by documenting monthly earned income of at least $580, which represents 80 hours at the federal minimum wage of $7.25 per hour.

The exemption categories define, by exclusion, the residual population that MCOs will serve after initial disenrollment. Exempt from the requirement are individuals classified as medically frail, pregnant and postpartum individuals through 12 months post-delivery, parents and caretakers of children under age 14, current and former foster youth through age 26, individuals within three months of release from incarceration, American Indians and Alaska Natives, veterans with a total disability rating, individuals currently participating in substance use disorder treatment programs, and individuals whose TANF work participation already satisfies the requirement by crosswalk. The rule does not exempt individuals who are simply unable to find work in high-unemployment labor markets, a design choice that Arkansas's experience with a narrower 2019 pilot suggests will produce substantial procedural disenrollment regardless of actual employment status.

States must generally begin implementation no later than January 1, 2027. CMS permits extensions through December 31, 2028 for states that require additional systems build-out, but extensions require a documented operational justification approved by CMS and are not automatic. The comment period for the IFR closed July 31, 2026; the rule took effect upon publication. Forty-three states plus the District of Columbia have expanded Medicaid under the ACA and are subject to the requirement. The seven non-expansion states are unaffected. CMS specifies that states requiring applicants and enrollees to document one month of qualifying activity before determining eligibility must begin outreach by September 2026 for a January 2027 compliance date; states requiring three months must begin outreach by July 2026.

Two Enrollment Projections and What They Mean for Rate Timing

The Congressional Budget Office projected, alongside the passage of H.R. 1, that work requirements would reduce Medicaid enrollment by approximately 5.2 million people in 2034, with 4.8 million of those becoming uninsured rather than transitioning to other coverage. Federal Medicaid spending reductions attributable to work requirements total $344 billion over the 10-year budget window. CMS's own projections are more near-term and more directly relevant to 2027 rate development: the agency estimates enrollment losses of 2.3 million in FY2027, rising above 3 million in subsequent years as state verification systems become more efficient and the backlog of retained-but-noncompliant enrollees processes through the system.

The gap between CBO's 4.8 million (2034 steady-state uninsured) and CMS's 2.3 million (FY2027 first-year total enrollment loss) reflects a specific implementation dynamic. Initial losses are constrained by state systems-readiness bottlenecks: data-matching infrastructure, eligibility worker capacity, and enrollee outreach effectiveness vary significantly across the 44 implementing jurisdictions. States that request December 2028 extensions are implicitly signaling that their verification infrastructure cannot support accurate compliance tracking by January 2027. In those states, the first-year enrollment loss will likely run below CMS's national average estimate, with larger losses arriving in 2028 and 2029 as compliance verification improves.

For managed care rate development, the distinction between these figures matters in a precise way. The 2.3 million first-year loss represents the enrollment shift that must be priced before the first FY2027 certification. The incremental losses between FY2027 and steady-state represent a continuing trajectory that will require mid-year rate adjustments unless certification language explicitly anticipates and accommodates them. Actuaries who certify FY2027 rates against the base period experience without population composition adjustment will produce certifications that are technically out of compliance with ASOP No. 49's requirement to account for "program changes that are known at the time of the analysis and that are likely to affect the expected costs of the covered population."

Who Exits: Health Status Patterns in Work Requirement Disenrollment

The core actuarial problem with CMS-2454-IFC is not the aggregate size of the enrollment reduction. It is the systematic health status of the people who leave.

Work requirement compliance is structurally correlated with good health. Adults who can work 80 hours per month are, on average, younger, healthier, and lower-cost than the full Medicaid expansion population. The exemption categories make this pattern more explicit: medically frail individuals are exempt, parents of young children are exempt, individuals in substance use disorder treatment are exempt, and veterans with total disability ratings are exempt. These categories represent a non-random subset of the enrolled population that is, by definition, higher-acuity. The people who fail to document compliance and are disenrolled are more likely to be work-capable, moderate-acuity adults than the exempted population that stays.

Arkansas provides the most directly applicable evidence. A 2019 New England Journal of Medicine study of Arkansas's work reporting requirement found that more than 95% of individuals targeted by the policy already met the requirement or should have been exempt from it. Despite this, approximately 18,000 people lost coverage in the first seven months, representing roughly 1 in 4 of those subject to the requirement. A Commonwealth Fund analysis found that Arkansas's work requirement was associated with a 4.4 percentage point increase in the uninsurance rate among 30-to-49-year-olds with incomes below 300% of FPL, with no measurable increase in employment. Researchers documented worsened medication adherence, delayed care, and rising medical debt among the disenrolled population.

The Arkansas evidence illuminates a two-layer disenrollment dynamic that managed care actuaries need to model separately. The first layer is procedural: workers who cannot navigate documentation requirements, individuals with unstable housing who miss renewal notices, and people in rural areas where electronic verification matching is incomplete. These procedural disenrollees are heterogeneous in health status. Some are healthy workers without documentation capacity. Others are chronically ill individuals who miss a verification step. The second layer, which emerges over time, is the genuine compliance pattern: individuals who cannot or do not perform 80 hours of qualifying activities and who do not qualify for exemptions. This second layer is more concentrated in the working-age moderate-acuity segment of the enrolled population.

KFF's Medicaid Enrollment and Unwinding Tracker documented that approximately 69% of disenrollments during the 2023-2024 post-pandemic unwinding were procedural, not eligibility-based. Applying that ratio to CMS-2454-IFC suggests that roughly 1.6 million of the 2.3 million FY2027 disenrollees will be procedural losses, and that the health status composition of the first-year departing population will be more mixed than the longer-term trajectory implies. By year two and beyond, the systematic pattern asserts itself: the residual concentrates toward exempt higher-acuity categories and loses the working-age moderate-acuity adults who eventually either comply or exit.

The net actuarial effect is a two-stage dynamic. First-year capitation rates calibrated on the pre-IFR population will be modestly understated for the residual, reflecting a moderate initial acuity shift. By year two, the understatement grows as the exempted high-acuity population becomes a larger share of the enrolled. Each rating period without composition adjustment widens the gap between the certified rate and the actual cost of the members being served.

The OBBBA APTC Prohibition and Why Coverage Does Not Redistribute

In a standard adverse selection scenario, when lower-acuity individuals exit a risk pool, some fraction transitions to other coverage. The departure of a work-capable adult from Medicaid would ordinarily create a pathway to ACA marketplace coverage via Advanced Premium Tax Credits if that individual's income qualified. Partial redistribution would absorb some of the acuity shift in the Medicaid pool by routing some lower-acuity disenrollees to the individual market.

Section 41106 of the One Big Beautiful Bill Act closes this pathway specifically for work requirement noncompliers. Individuals who are disenrolled from Medicaid because they failed to satisfy the community engagement requirement are prohibited from receiving APTCs, regardless of income. A 35-year-old earning $28,000 who is disenrolled because he could not document his required hours cannot purchase a subsidized ACA plan. He can purchase an unsubsidized plan, a decision that CMS enrollment data suggest fewer than 3% of individuals at that income level make. The effective outcome is uninsured status.

This is the mechanism behind CBO's finding that 4.8 million of the 5.2 million work-requirement-driven Medicaid coverage losers become uninsured rather than transitioning to other coverage. The APTC prohibition channels coverage loss into uncompensated care rather than redistributing it across the insurance market. For managed care actuaries, the practical consequence is that there is no compensating redistribution of healthy workers to the individual market that would partially offset the capitation pricing problem. Hospitals and safety-net providers absorb the cost shift on the uncompensated care side. MCOs retain the higher-acuity residual at rates calibrated for a population that included the now-departed healthy workers.

The interaction also affects how actuaries should model the ACA individual market morbidity shift. Under prior work requirement proposals, health economists assumed that some fraction of Medicaid work requirement disenrollees would eventually appear in the ACA risk pool, importing a morbidity shift that ACA rate filings would need to absorb. The APTC prohibition largely eliminates that pathway. ACA actuaries working on 2027 and 2028 filings should not expect significant enrollment inflow from this population, which removes one source of individual market morbidity pressure but also removes the partial redistribution mechanism that would have allowed some healthy workers to stabilize the ACA pool.

The 12-Month Rate Cycle Against a January 2027 Enrollment Shock

CMS released the 2025-2026 Medicaid Managed Care Rate Development Guide in August 2025, and the 2026-2027 guide in February 2026. Neither document contains guidance on adjusting capitation rates for work requirement enrollment composition effects, because neither was written against an effective IFR. States currently certifying rates for rating periods beginning January 2027 are operating without CMS-issued methodology for the central actuarial challenge their certifications face.

The standard rate development timeline for a January 2027 rating period would have begun base period data selection in mid-2026, with certification submissions to CMS by late summer or early fall 2026. The IFR published June 1, 2026, landed inside the rate development window for some states. For states further along in their certification process, adding a CMS-2454-IFC population composition adjustment requires reopening work that was substantially complete. The alternative, certifying without the adjustment and relying on mid-year rate amendment provisions, shifts the exposure from the certification to the MCO's balance sheet for however many months elapse before an amendment takes effect.

MACPAC's 2022 analysis of managed care rate-setting documented a mean adjustment delay of 7.4 months between program change effective date and certification update. Applied to a January 2027 program change, that lag implies rate corrections reflecting post-IFR population composition will not reach effective rates until August 2027 under a normal timeline. MCOs that are contractually entitled to capitation rate renegotiation only at the annual rating period renewal have no mechanism for interim adjustment. Their exposure runs for a full rating period at pre-IFR rates.

The six-month redetermination requirement running parallel to work requirements compounds the timing problem. States that are simultaneously accelerating eligibility redetermination cycles and implementing work requirement verification face overlapping operational demands on eligibility systems. The redetermination cycle affects the total enrolled population; work requirements affect a specific subset. But both create mid-year enrollment composition shifts that standard annual rate development cycles were not designed to capture.

Four Dimensions of the Managed Care Capitation Adjustment

Standard capitation rate development applies base period risk scores to projected enrollment and trends forward using service category and utilization factors. CMS-2454-IFC requires explicit adjustments along four dimensions that the standard methodology does not address.

Risk score migration is the first. The Chronic Illness and Disability Payment System with Rx (CDPS+Rx) scores that most states use to adjust capitation rates for population acuity are prospectively calibrated on diagnostic history from claims data. As lower-acuity work-capable enrollees exit, the average CDPS+Rx score of the residual population rises. States using risk score-adjusted capitation, paying higher PMPM amounts for high-cost chronic condition cohorts, will see the distribution of their enrolled population shift toward higher-score categories. The certification assumption about the average risk score of the covered population requires explicit revision to reflect anticipated post-IFR composition, not just anticipated enrollment volume.

Stop-loss and carve-out mechanics are the second dimension. MCOs that purchase stop-loss reinsurance on high-cost claimants will see the probability of attachment increase as the proportion of members with chronic conditions rises. Attachment points calibrated on the pre-IFR member mix will be breached more frequently. For programs that carve out specialty pharmacy from managed care capitation, the post-IFR residual will include a higher share of members whose total drug spend is carve-out eligible. This reduces per-member cost in the managed care capitation base while increasing carve-out liabilities, creating a cost-shifting dynamic that can be misread as improved MCO performance if the carve-out is not tracked against the enrollment composition shift simultaneously.

Mid-year enrollment shift provisions are the third. MCOs should negotiate explicit capitation re-opener clauses before January 2027 that trigger rate adjustment if enrollment falls outside a specified tolerance band (typically 5-10% of certified assumptions) or if the average CDPS+Rx score of the enrolled population shifts by more than a defined threshold. The state-directed payment structure affects how re-opener economics flow between state agencies and MCOs, particularly for programs where SDP pass-through amounts are a material share of total capitation. Re-openers negotiated without accounting for the SDP decomposition may produce rate adjustments that address the base capitation gap but leave the SDP pass-through component mispriced.

Specialty drug and gene therapy concentration is the fourth. The medically frail and disabled exemption categories include exactly the populations with the highest probability of specialty drug utilization and gene therapy eligibility. As working-age moderate-acuity adults exit and exempted high-acuity populations concentrate, the probability that any given MCO's book contains members eligible for high-cost specialty treatment rises. An MCO managing 200,000 expansion members and retaining 180,000 post-IFR will not simply have a proportionally smaller book with the same cost structure. The 180,000 remaining members carry systematically higher per-member specialty drug and gene therapy exposure. Stop-loss aggregates calibrated on the pre-IFR book size and composition are likely to be inadequate for the post-IFR residual unless explicitly restressed.

ASOP No. 49 Certification: What the Standard Now Requires

ASOP No. 49 Section 3.3 requires the certifying actuary to consider "program changes that are known at the time of the analysis and that are likely to affect the expected costs of the covered population." CMS-2454-IFC is a known program change with an effective date of January 1, 2027 and a documented CMS enrollment loss projection. A rate certification for a period beginning January 2027 that does not address the anticipated enrollment composition shift is incomplete on its face under ASOP 49's own terms.

ASOP No. 49 Section 3.4 requires disclosure of material limitations on actuarial soundness, including limitations arising from program changes not yet reflected in base period data. The standard does not prescribe the adjustment methodology; it requires that the actuary document the assumptions used and disclose the uncertainty range. In the absence of CMS-issued adjustment guidance specific to the IFR, the certifying actuary must develop the methodology independently. The most defensible approach builds three scenarios: low, central, and high enrollment loss, calibrated against the CDPS+Rx risk score differential between likely-disenrolled and likely-retained member segments, drawing on the Arkansas and 2023-2024 unwinding evidence as the primary analog data sources.

States and MCOs that accept rate certifications based solely on the historical base period without explicit IFR adjustment are accepting an actuarial soundness exposure that will materialize in claims experience within two to three quarters of January 2027. The 7.4-month average amendment delay documented by MACPAC means that exposure will run for at least two quarters before correction, and potentially longer in states that elect the December 2028 extension.

What Actuaries Should Monitor Through 2027

Three indicators will determine how quickly the actuarial pricing gap opens after January 1, 2027 and how durable it proves to be.

State verification infrastructure quality is the most important variable. States with robust wage record access and real-time Medicaid eligibility system integration will produce lower procedural disenrollment rates and more predictable enrollment composition changes. States with weaker infrastructure will see higher procedural disenrollment early, a mixed-acuity initial exit that is harder to price, followed by gradual acuity concentration in the residual as the compliance system improves. Extension elections through December 2028 are a proxy signal: states electing the maximum extension are implicitly acknowledging that their verification systems cannot support accurate compliance tracking on the January 2027 timeline, and their capitation adjustments will require more aggressive uncertainty margins.

MCO medical loss ratios in the Medicaid expansion segment will be the first empirical signal from plan financials. MCOs that report MLRs rising faster than capitation rate increases in their expansion books by Q2 or Q3 2027 will be providing early evidence that acuity concentration is exceeding pre-IFR certification assumptions. The signal will be clearest in states that elected January 2027 implementation without extension; in extension states, the MLR signal will lag by six to eighteen months.

Specialty pharmacy and high-cost claimant frequency in the residual population will appear in MCO stop-loss attachment data and pharmacy cost trend analyses by mid-2027. Plans that track CDPS+Rx score distribution in their enrolled population monthly will be able to separate the acuity concentration signal from general medical trend before it reaches the income statement. Plans that do not track composition will discover the problem in their financials, not their enrollment data.

The capitation adequacy problem from non-random disenrollment is not unprecedented. The 2023-2024 unwinding created a smaller version of the same dynamic: procedural disenrollments produced a residual population that was systematically different from the pre-unwinding mix, and states had to issue rate amendments as the evidence accumulated. What CMS-2454-IFC adds is permanence, scale, and the OBBBA APTC block that prevents the normal redistribution dynamic. Managed care actuaries certifying rates for January 2027 programs are not adjusting for a temporary administrative disruption. They are repricing a population whose composition will diverge from historical base periods for years, along a trajectory that the exemption structure defines in advance.